--2025/Q1-- / 13.200M--
--2024/Q4-- / 15.122M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 25.050
- +1.470+6.23%
Close Nov 22 16:00 ET
- 25.050
- 0.0000.00%
Post 19:53 ET
2.07BMarket Cap-15854P/E (TTM)
25.430High23.180Low1.19MVolume23.600Open23.580Pre Close29.42MTurnover1.73%Turnover RatioLossP/E (Static)82.81MShares49.50052wk High2.62P/B1.72BFloat Cap20.84052wk Low--Dividend TTM68.63MShs Float138.522Historical High--Div YieldTTM9.54%Amplitude13.000Historical Low24.782Avg Price1Lot Size
Beam Therapeutics Key Stats
Beam Therapeutics Q3 2024 Earnings Date
Currency：USDNov 5, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 14.13M | 14.27M | +137.03K |
| Beat Est. | -17.80% | -17.01% | +0.97% |
| EPS | -1.15 | -1.17 | -0.02 |
| Miss Est. | +6.12% | +4.10% | -2.17% |
Analyst Rating
Nov 6, 2024
Beam Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Beam Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
